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Abstract Obsessive compulsive disorder (OCD) and
attention deficit hyperactivity disorder (ADHD) are two of
the most common neuropsychiatric diseases in paediatric
populations. The high comorbidity of ADHD and OCD
with each other, especially of ADHD in paediatric OCD, is
well described. OCD and ADHD often follow a chronic
course with persistent rates of at least 40–50 %. Family
studies showed high heritability in ADHD and OCD, and
some genetic findings showed similar variants for both
disorders of the same pathogenetic mechanisms, whereas
other genetic findings may differentiate between ADHD
and OCD. Neuropsychological and neuroimaging studies
suggest that partly similar executive functions are affected
in both disorders. The deficits in the corresponding brain
networks may be responsible for the perseverative, com-
pulsive symptoms in OCD but also for the disinhibited and
impulsive symptoms characterizing ADHD. This article
reviews the current literature of neuroimaging, neuro-
chemical circuitry, neuropsychological and genetic find-
ings considering similarities as well as differences between
OCD and ADHD.
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Introduction
Obsessive compulsive disorders (OCD) are typically char-
acterized by the presence of recurrent, intrusive, and dis-
turbing thoughts (obsessions) which often elicit anxiety or
emotional stress followed by repetitive stereotypic behav-
iour or thoughts (compulsions) in order to neutralize the
negative affects (American Psychiatric Association 1994).
According to ICD-10 diagnostic classification, OCD con-
sists of recurrent and persistent thoughts, behavioural pat-
terns, ideas, and impulses that impose themselves against
internal resistance, experienced by the patient as excessive
and distressing. According to ICD-10 (World Health
Organization 1996), OCD can be divided into ‘‘predomi-
nantly obsessional thoughts’’, ‘‘predominantly compulsive
acts’’, or in a subtype of combination of both ‘‘obsessions
and compulsions’’. Fear of contamination, sexual, hypo-
chondriac, and excessive thoughts including scruples/guilt
are the most commonly reported obsessions and washing,
repeating, checking, and ordering are the most commonly
reported compulsions (Geller et al. 2001). In the DSM-5
(American Psychiatric Association 2013), OCD is newly
classified into the diagnostic categories: ‘‘obsessive
compulsive and related disorders’’ including ‘‘obsessive
compulsive disorder’’, and as related disorders e.g.‘‘body
dysmorphic disorder’’, ‘‘hoarding disorder’’, ‘‘hair pulling
disorder’’ (trichotillomania). In the previous DSM-IV, OCD
was classified as a subcategory of anxiety disorders.
Therefore, in DSM-5, the specificity of the symptomatology
including obsessions and compulsions with or without
concomitant anxiety comes more to the centre of attention.
In DSM-IV, the diagnostic criteria for children with
OCD differs from adults with OCD in regard to not having
always insight into the senselessness of the obsessive
behaviour. For adults, ‘‘showing insight into the sense-
lessness of the symptoms’’ was one of the key criteria to
differentiate OCD from psychosis; see also ICD-10. In
DSM-5, clinicians even have to specify the degree of
insight into the symptomatology: good/fair, poor, or absent
insight. The presence of insight is of clinical importance
because insight not only correlates with age but also with
severity and positive therapy response (Walitza 2014).
Clinicians also have to specify whether the patient has a
current or past history of a tic disorder, this will be clas-
sified as a tic-related obsessive compulsive disorder
(American Psychiatric Association 2013; Thomsen 2013;
Walitza 2014). In the overview presented here, nearly all
studies have used ICD-10 or DSM-IV for the classification
of OCD in children and adults. Therefore, we want to
anticipate that questions of confounding variables of the
degree of insight and of the influence of previous or present
tic disorders could not be answered by most of the previous
findings and should be addressed using the DSM-5 criteria
in future studies.
From an epidemiological point of view, OCD is the
world’s fourth most common psychiatric disorder with a
lifetime prevalence of 2–3 % (Flament et al. 1988; Robins
et al. 1984; Zohar 1999). Delorme et al. (2005) considered
the disorder to have a bimodal age distribution, with a first
peak at age 11 and a second in early adulthood. Up to 50 %
of all OCD cases emerge during childhood or adolescence
(Flament et al. 1988; Nestadt et al. 2000). The course and
outcome show high persistence rates with at least 40 % in
retrospective and prospective follow-up studies in OCD
(Stewart et al. 2004; Zellmann et al. 2009) whereby
patients in remission with OCD often developed other
psychiatric disorders and other psychiatric symptoms,
exacerbated by the decrease of OCD symptoms (Stewart
et al. 2004).
Attention deficit hyperactivity disorder (ADHD) is
characterized by a persistent pattern of inattention and/or
hyperactivity and impulsivity (American Psychiatric
Association 1994). The symptomatology of ADHD inter-
feres with functioning or development and has persisted
(for at least 6 months) to a degree that is inconsistent with
expected developmental level and that negatively impacts
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directly on social and academic/occupational activities.
Manifestations of the disorder must be present in more than
one setting (e.g. school, home, with friends or relatives).
The symptoms vary depending on context, the higher the
structure of the context (e.g. school), the higher seems to be
the deviation from the average of normal behaviours. But it
has to be taken into account that some forms of structure of
school and homework can also help the child to focus more
on important topics. According to DSM-5 criteria, ADHD
is now classified as a neurodevelopmental disorder, which
is a group of conditions with onset in the developmental
period. These disorders (also including autism spectrum
disorders and learning disorders) typically manifest in early
development, often before the child enters grade school,
and are characterized by developmental deficits that pro-
duce impairments of a broad range of social functioning
(American Psychiatric Association 2013). Several inatten-
tive or hyperactive–impulsive symptoms must have been
present prior to age of 12 years (previously in DSM-IV, the
symptomatology has to be present before age of 7 years).
Therefore, we can assume that ADHD has on average an
earlier onset of symptoms in comparison with OCD. DSM-
5 distinguishes three different presentations: a predomi-
nantly inattentive presentation, a predominantly hyperac-
tive/impulsive, and a combined presentation, if criteria for
both inattention and hyperactivity–impulsivity are met.
Although the lists of 18 symptoms from the DSM-5
(American Psychiatric Association 2013) and the ICD-10
(World Health Organization 1996) for ADHD are similar,
ICD-10 is more specific as some symptoms must be present
in all of the three dimensions (inattention, hyperactivity,
and impulsivity). And hyperkinetic disorder (the nomen-
clature used in the ICD-10 that corresponds to ADHD in
the DSM-5) is excluded if depression and/or anxiety dis-
orders are also identified. In DSM-5, autism spectrum
disorders, too, are no exclusion criteria for ADHD
anymore.
ADHD has a higher prevalence than OCD and is overall
one of the most common psychiatric disorders, with a
worldwide prevalence of 5.2 % among children and ado-
lescents (Polanczyk et al. 2007) using DSM-IV and DSM-5
criteria. ADHD persists into adulthood in 60–70 % of cases
either as a residual or as a full clinical disorder (Biederman
et al. 2000; Kessler et al. 2005). The estimated prevalence
of adult ADHD in USA, Europe, and the Middle East is
3.4 % (range 1.3–7.3 %) (Fayyad et al. 2007; Kessler et al.
2006).
A study concerning the relationship between OCD and
ADHD in children and adolescents using familial risk
analysis provided further evidence of a familial relation-
ship, in addition to unique aetiological factors for both
OCD and ADHD (Geller et al. 2007a, b). This is of special
importance because of the high comorbidity for both OCD
and ADHD disorders. Sheppard et al. (2010) ascertained in
a recent study an ADHD prevalence of 11.8 % in OCD-
affected individuals. Masi et al. reported 2006 and 2010 in
two samples of consecutive referred paediatric OCD
patients a prevalence for comorbid ADHD of 17.1 % and
25.5 % respectively (Masi et al. 2006, 2010). The esti-
mated rate of comorbid OCD among children with ADHD
is 8 % (Geller et al. 2000). In our studies, ADHD was the
most common comorbidity in early-onset OCD, in which
tic and Tourette syndrome were exclusion criteria (Walitza
et al. 2008). In this study, comorbidity of ADHD in early-
onset OCD seems also to predict a higher severity of OCD
and a higher grade of persistence of OCD in a prospective
follow-up period (Walitza et al. 2008).
This article aims to summarize and compare findings of
structural and functional abnormalities, neuropsychological
aspects, biochemical and genetic studies on OCD and
ADHD. Despite the high comorbidity of both disorders,
only very few studies have investigated both together or
have directly compared both within the same study. This
article shows in the following those rare studies investi-
gating both disorders and also results of each disorder
alone (focusing on meta-analyses, if possible) with a fol-
lowing contrast made by the authors of the present review.
Some of the results showed shared aetiological factors and
mechanisms for both disorders, whereas other findings
differentiated between ADHD and OCD. The aim of this
overview is to help to understand the aetiology of psychi-
atric disorders, in particular concerning ADHD and OCD.
Structural and functional abnormalities in OCD
and ADHD
A major aim in recent years has been to shed light on the
relationship between clinical symptoms of ADHD and OCD
and the underlying brain structure, function, and connec-
tivity. Extensive neuroimaging literature exists on the
comparison of either disorders with matched healthy con-
trols, and a variety of methods have been used to assess brain
structure, metabolism, and the spatial and temporal organi-
zation of brain networks. The timing of information pro-
cessing is commonly studied with brain imaging methods
that exhibit a high temporal resolution in millisecond time
range, such as electroencephalography (EEG) or alterna-
tively by magnetoencephalography. Details about brain
structure and the spatial activation pattern are best assessed
by (functional) magnetic resonance imaging or positron
emission tomography (PET). Here, we summarize the most
consistent abnormalities found in brain structure and func-
tional activation patterns revealed by structural magnetic
resonance imaging, functional magnetic resonance imaging
(fMRI), and event-related potentials (ERP) studies for both
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ADHD and OCD. We focused on similarities and differences
of affected brain regions reported across these patient groups
and specifically point to meta-analytic studies and their
findings. Concluding this section, we summarize the results
of the only study that directly compared functional neuro-
imaging data of paediatric patients with ADHD to patients
with OCD (Rubia et al. 2010, 2011).
There is considerable evidence for structural differ-
ences in the brains of ADHD patients when compared to
age-matched healthy controls. Most of these findings are
relatively inconsistent and depend on age and/or medi-
cation with stimulants. Regarding age, it has been shown
that patients with ADHD show a regional delay in the
maturation of cortical thickness, especially in regions
responsible for cognitive control such as attention,
working memory, inhibition and evaluation of reward
contingencies in the prefrontal cortex (Shaw et al. 2007),
and a slightly earlier maturation of the primary motor
cortex. The authors thus suggested that the abnormal
development of cognitive control and motor areas may
drive the poor control of motor activity (Shaw et al.
2007).
Recent meta-analyses summarized the most consistently
replicated structural differences between ADHD patients
and controls. They emphasize the reduced volume of the
basal ganglia, especially the lentiform nucleus (globus
pallidus and putamen) (Ellison-Wright et al. 2008; Nakao
et al. 2011) and the caudate (Ellison-Wright et al. 2008;
Frodl and Skokauskas 2012; Nakao et al. 2011; Valera
et al. 2007) seen in ADHD patients. More specifically, the
abnormal size of the caudate seems to depend on age and
has been reported to be most prominent in prepubescents
with ADHD (Carrey et al. 2012; Castellanos et al. 2002;
Mahone et al. 2011). Furthermore, partial normalization of
the basal ganglia volume was found when ADHD patients
were treated with stimulant medication (Nakao et al. 2011).
Apart from an increased volume of the posterior cingulate
cortex, other often reported abnormalities in the form of
reduced cortical thickness and/or volume of the total brain
(Castellanos et al. 1996, 2002; Hill et al. 2003), corpus
callosum (Giedd et al. 1994; Hill et al. 2003), prefrontal
(Hill et al. 2003; Shaw et al. 2007; Sowell et al. 2003),
temporal (Sowell et al. 2003), and cerebellar cortex (Cas-
tellanos et al. 1996, 2002) did not reach significance in the
most recent meta-analysis of Nakao et al. (2011). Similarly
to ADHD patients, OCD patients showed consistent devi-
ations in the volume of the basal ganglia (Piras et al. 2013,
Rotge et al. 2010). Older studies were inconsistent on
whether this structure showed enlarged (Baxter et al. 1987,
1988; Scarone et al. 1992), decreased (Luxenberg et al.
1988; Robinson et al. 1995), or normal volume (Aylward
et al. 1996; Jenike et al. 1996; Szeszko et al. 2008) in
patients (for comprehensive reviews see: Saxena and
Rauch 2000; Friedlander and Desrocher 2006; Huey et al.
2008). A review (Piras et al. 2013) and two meta-analyses
(Radua and Mataix-Cols 2009, Rotge et al. 2010) pointed
to relatively consistent patterns of increased basal ganglia
volume in more recent studies. Besides alterations in basal
ganglia, the meta-analyses of structural differences
between OCD patients and healthy controls also detected
reduced grey matter in the frontal eye fields, the dorsolat-
eral prefrontal cortex, and the medial frontal cortex,
including the anterior cingulate cortex (ACC) (Radua and
Mataix-Cols 2009), the left and right orbito-frontal cortex
(OFC), and the supramarginal gyrus (Rotge et al. 2009,
2010). An overview of the regions with altered grey matter
volumes in patients, as reported in the above-mentioned
meta-analyses (Ellison-Wright et al. 2008; Frodl and
Skokauskas 2012; Nakao et al. 2011; Rotge et al. 2010;
Radua and Mataix-Cols 2009), is given in Fig. 1.
The structural abnormalities thus nicely converge with
the neurobiological models, suggesting a failure of cortico-
striato-thalamico-cortical (CST) circuit function in ADHD
and OCD patients (van den Heuvel et al. 2010).
In line with structural findings, the results of a meta-
analysis in adult OCD patients pointed to activation dif-
ferences in corresponding functional brain networks (Brem
et al. 2012; Menzies et al. 2008). Apart from clear support
for abnormal activation in orbito-fronto-striatal regions,
lateral frontal, anterior cingulate, middle occipital, and
parietal cortices, the cerebellum also exhibited altered
activation in cognitive tasks (Menzies et al. 2008). A pre-
liminary meta-analysis in paediatric OCD patients largely
converged with these findings, even though the direction of
activation differences yielded partly opposing results
(Brem et al. 2012). The alterations in the activation pattern
of ADHD differed between children and adults as shown in
a recent meta-analysis. Both adults and children yielded
hypoactivation in fronto-parietal executive function net-
works that have been related to the well-known deficien-
cies in performing goal-directed executive processes and
hyperactivation in the default network, suggesting a faulty
interregulation between the networks activated during tasks
and the default network (Cortese et al. 2012). Further
alterations in activation have been detected in the ventral
attention and the somatomotor networks in children and in
the visual and dorsal attention systems in adults (Cortese
et al. 2012).
The ACC converged in showing both structural and
functional alterations in ADHD and OCD patients as
compared to healthy controls. The ACC has an important
role in attentional and emotional processes (Bush et al.
2000; van Veen and Carter 2002a) but, moreover, is also
involved in conflict detection and evaluation (Botvinick
et al. 1999; Carter et al. 2000; Durston et al. 2003a; Rid-
derinkhof et al. 2004; Ullsperger and von Cramon 2004)
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and performance monitoring (Albrecht et al. 2010, 2008;
Maltby et al. 2005; Ridderinkhof et al. 2004; Ullsperger
and von Cramon 2004, 2006; Ursu et al. 2003). The
characteristic overactivation of this brain structure in OCD
patients points to excessive activity in the action moni-
toring system when processing errors or correct responses
in high-conflict trials (Maltby et al. 2005; Ursu et al. 2003)
and has thus been suggested to reflect a neural correlate of
the patients’ continuing sense that something is not quite
‘‘right’’ (review see: Aouizerate et al. 2004) and requires
correction. In contrast, performance monitoring and error
and conflict processing in ADHD patients seem to induce
less activation in the ACC as demonstrated by fMRI
(Durston et al. 2003b; Rubia et al. 2010, 2005; Tamm et al.
2004) and ERP studies (Albrecht et al. 2010, 2008; Groen
et al. 2008; Liotti et al. 2005; McLoughlin et al. 2009; van
Meel et al. 2007). The high time resolution of ERPs allows
one to better disentangle conflict-related from actual error-
related effects through response-locked averaging. An
electrophysiological correlate of ACC activity which can
be detected in the ERP is the response-locked error-related
negativity (ERN, Ne) occurring at around 50–150 ms after
error commission. Holroyd and Coles suggested that the Ne
emerges when a phasic error signal originating from the
mesolimbic dopamine system is processed in the ACC in
order to modify performance and update behaviour (Hol-
royd and Coles 2002). The characteristic fronto-central
negativity of this Ne in OCD and ADHD has shown to
differ from controls. The more pronounced Ne amplitudes
found in children (Endrass et al. 2008; Grundler et al. 2009;
Johannes et al. 2001) as well as in adults with OCD
(Hajcak et al. 2008; Santesso et al. 2006) are in line with
the stronger ACC activity seen in fMRI studies. In contrast
to OCD patients with their overactive response monitoring
system, patients with ADHD show diminished Ne and
ACC activity (Albrecht et al. 2010, 2008; Bush et al. 1999;
Durston et al. 2003b; Groen et al. 2008; Liotti et al. 2005;
McLoughlin et al. 2009; Rubia et al. 1999; Tamm et al.
2004; van Meel et al. 2007). A very recent meta-analysis of
the Ne in adolescent and adult patients with ADHD clearly
supported previous findings of Ne attenuation (Geburek
et al. 2013) and provides further evidence for a deficit in
cognitive control mechanisms.
Anterior cingulate cortex activity has not only been
related to performance monitoring and conflict anticipation
(Sohn et al. 2007) or processing but seems crucial for
inhibition processes as well. Thus, ACC overactivity in
OCD may, in addition to excessive performance moni-
toring, also indicate a failure in the inhibition of prepotent
responses in OCD patients causing the repetitive behaviour
of compulsions (Maltby et al. 2005). The neurobiological
correlates of inhibitory deficits in ADHD contrast to the
ones of OCD patients because deficient inhibition mainly
emerged as ACC hypoactivation in STOP or flanker tasks
(Konrad et al. 2006; Pliszka et al. 2006; Rubia et al. 1999).
Hypoactivation and corresponding deficient inhibition in
ADHD seem responsible for inappropriate higher-order
motor control mechanisms (Rubia et al. 1999). On the
other hand, and probably depending on the task, hyper-
activation can occur in similar cortical and subcortical
structures of ADHD patients (Durston et al. 2003b; Schulz
et al. 2004).
Fig. 1 The centres of the clusters that showed differences in grey
matter volumes of patients with ADHD or OCD in five recent meta-
analyses (Ellison-Wright et al. 2008; Frodl and Skokauskas 2012;
Nakao et al. 2011; Rotge et al. 2010; Radua and Mataix-Cols 2009)
are plotted as spheres (r = 4 mm) on sagittal (top) and axial slices
(bottom) using MRICron (Rorden et al. 2007). Alterations in the grey
matter volumes of patients with ADHD are shown in blue and of
patients with OCD in red/yellow. Nicely visible are the differences in
the volume of the basal ganglia in ADHD (reduced volume: light
blue) and OCD (increased volume: yellow) as compared to controls
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ERPs associated with inhibition processes include the
fronto-central N2 (or N200) negativity after 200–300 ms
and a later (350–600 ms) fronto-central P3 (or P300)
positivity. These ERPs have usually been studied with
STOP and Go/Nogo tasks (Brandeis et al. 1998; Fal-
kenstein et al. 1999; Kopp et al. 1996). More pronounced
amplitudes characterize the N2 and the P3 in response to
trials requiring behavioural inhibition, such as Nogo as
compared to Go trials. Regarding the N2, the findings in
OCD patients are inconsistent: depending on the task,
authors reported comparable (Di Russo et al. 2000),
enhanced (Ruchsow et al. 2007), or reduced amplitudes
and different topographies (Kim et al. 2007) to Nogo
trials in the N2. For ADHD, the deficits in the right
frontal N2 seemed to dominate in STOP tasks with a
high inhibition demand (Albrecht et al. 2005; Dimoska
et al. 2003; Liotti et al. 2005; Pliszka et al. 2000). The
N2, generated in the caudal region of the ACC, precedes
the actual motor response during conflicting trials (van
Veen and Carter 2002b). Even though the N2 has tradi-
tionally been associated with inhibitory processes, the
modulation of its amplitude by conflict level indicated
that the N2 primarily reflects conflict processing rather
than motor inhibition (Donkers and van Boxtel 2004;
Enriquez-Geppert et al. 2010; van Veen and Carter
2002a).
Accordingly, a recent study showed that the conflict-
induced amplitude increase in the N2 was significantly
reduced in children with ADHD. Furthermore, non-
affected siblings exhibited intermediate amplitudes in
between ADHD subjects and healthy peers (Albrecht et al.
2010, 2008). The subsequent P3 has been associated with
phasic inhibitory motor control mechanisms emerging
from the right frontal cortex (Strik et al. 1998). The Nogo
P3 typically shows an anteriorisation (Nogo anteriorisa-
tion) of its central positivity in contrast to Go trials
(Fallgatter and Strik 1999) which has been related to ACC
activity and prefrontal response control (Fallgatter et al.
2005). Most often, the P3 in visual Go/Nogo tasks did not
differ in amplitude between patients with OCD and con-
trols, even though its latency (Johannes et al. 2001) and
topography sometimes differed (Herrmann et al. 2003;
Malloy et al. 1989). In contrast, studies on ADHD show
quite consistent differences in the Nogo P3. Both children
and adults with ADHD showed reduced amplitudes and
diminished Nogo anteriorisation in the narrow time win-
dow preceding actual response inhibition in the P3
(Fallgatter et al. 2004, 2005).
A direct comparison of functional activation between
ADHD and OCD patients is only available from a paedi-
atric sample and for tasks concentrating on executive
functions. The group of Rubia examined interference
inhibition, selective attention (Rubia et al. 2011), motor
response inhibition, and cognitive flexibility (Rubia et al.
2010) using event-related fMRI. Common dysfunction in
paediatric patients with ADHD or OCD as compared to
controls emerged as hypoactivation in mesial frontal areas:
reduced activity in patients was found in the right orbito-
frontal cortex and ACC for successful inhibition, in the left
medial frontal cortex and ACC for failed inhibition, and
finally in bilateral inferior frontal and insular cortices
extending also to the left premotor cortex, right superior
temporal areas, and putamen for cognitive switching pro-
cesses (Rubia et al. 2010). Further interference inhibition
and selective attention in a modified Simon task was
associated with reduced activity in supplementary motor
areas, the ACC and superior parietal cortices in both
patient groups (Rubia et al. 2011).
Disorder-specific hypoactivation was predominantly
found for ADHD patients and again was condition and task
specific: activation in the left putamen, caudate, cingulate,
and parietal cortex was reduced as compared to healthy
controls and OCD patients during cognitive switching
(Rubia et al. 2010) and in the Simon task (Rubia et al.
2011). The pattern of functional deficits in the basal gan-
glia thus corresponds to the consistent structural abnor-
malities reported for ADHD (Ellison-Wright et al. 2008;
Nakao et al. 2011). Failed stop trials were furthermore
associated with diminished right middle and inferior pre-
frontal activation in ADHD as compared to healthy con-
trols and OCD patients (Rubia et al. 2010).
Disorder-specific alterations in brain activation of chil-
dren with OCD were less pronounced. They differed from
healthy controls and ADHD patients only in the oddball
condition by showing reduced activation in the right
superior and middle frontal gyri of the dorsolateral pre-
frontal cortex (Rubia et al. 2011). It however remains
questionable whether this finding is confounded by effects
of medication and symptom severity in the relatively small
group of partly remitted OCD patients with only low
symptom levels (Rubia et al. 2010).
In summary, deficits in the cortico-striato-thalamic
circuits responsible for cognitive control and perfor-
mance monitoring processes are characterized in both
neuropsychiatric conditions: ADHD and OCD. Accord-
ing to the nature of their symptoms situated at the
opposite ends of the impulsive–compulsive spectrum,
they either exhibit hypo- or hyperactivation of affected
brain structures such as basal ganglia or the mesial
frontal cortex (Rubia et al. 2010; Carlsson 2000).
Affected CST networks and the resulting deficits in
cortical inhibition and/or disinhibition may thus, on the
one hand, facilitate the perseverative, compulsive
behaviours seen in OCD patients but, on the other hand,
also explain the disinhibited, impulsive, inattentive
behaviour of ADHD patients.
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Neuropsychological aspects in OCD and ADHD
Neuropsychological deficits have been described for
adults with OCD in the domain of executive functions,
especially impaired inhibition, impaired control of
interference/conflict, diminished cognitive flexibility in
switching, and cognitive alternation tasks (Abbruzzese
et al. 1997; Aycicegi et al. 2003; Chamberlain et al.
2006, 2007; Gu et al. 2008; Remijnse et al. 2006; Veale
et al. 1996; Watkins et al. 2005), as well as impaired
planning (Cavedini et al. 2001; Chamberlain et al. 2007;
Mataix-Cols et al. 2002; Nielen and Den Boer 2003; van
den Heuvel et al. 2005). Several studies report problems
in visuo-spatial working memory (Moritz et al. 2011;
Savage et al. 1996), implicit learning tasks (Goldman
et al. 2008; Kathmann et al. 2005), and, less consis-
tently, visuo-spatial learning (see Simpson et al. 2006;
Penades et al. 2005; Savage et al. 1999; meta-analyses
by Olley et al. 2007; Abramovitch et al. 2013; but see
analysis by Harkin and Kessler 2011). Deficits in motor
and processing speed have also been reported (Burdick
et al. 2008) with slower responding in OCD compared
to controls. Only few studies have investigated neuro-
psychological performances in paediatric OCD, which
partly replicate findings from OCD in adults on
impaired inhibition (Rosenberg et al. 1997; Woolley
et al. 2008; but see Beers et al. 1999; Shin et al. 2008;
Ornstein et al. 2010), cognitive flexibility (Shin et al.
2008; Ornstein et al. 2010; but see Beers et al. 1999),
planning (Andres et al. 2007; Behar et al. 1984; Cox
et al. 1989; but see Beers et al. 1999), and visual
memory (Andres et al. 2007; but see Behar et al. 1984 ;
Cox et al. 1989). Poor fine motor skills and visuo-spatial
skills in paediatric OCD seem to predict the persistence
of OCD into adulthood (Bloch et al. 2011). Neuropsy-
chological deficits have also been found in remitted
OCD (Chamberlain et al. 2007; Rao et al. 2008) or in
close relatives (Chamberlain et al. 2008), which sug-
gests that they are trait markers or endophenotypes of
OCD. In ADHD research, a large number of studies
have investigated neuropsychological functioning both
in children and adults. There is agreement that neuro-
psychological deficits in ADHD are heterogeneous and
that only about 30–50 % of ADHD patients present
clinically relevant neuropsychological impairment when
assessed by objective tests (Biederman et al. 2004;
Lambek et al. 2011; Loo et al. 2007; Nigg et al. 2005).
Meta-analyses report consistent deficits in the domains
of response inhibition, vigilance, planning, and working
memory (Huang-Pollock et al. 2012; Kasper et al. 2012;
Willcutt et al. 2005) in children; verbal fluency, inhi-
bition, set-shifting (Boonstra et al. 2005), and focused
and sustained attention (Balint et al. 2009) in adults;
and interference control and enhanced reaction time
variability in both (Kofler et al. 2013; Lansbergen et al.
2007).
Cognitive style and error processing
Metacognition is impaired in OCD and the cognitive style
of patients with OCD is marked by doubts about their own
performance (Hermans et al. 2008; but see Moritz et al.
2011) and an overly cognitive self-consciousness which
might interfere with effortful encoding (Exner et al. 2009;
Kikul et al. 2011). The opposite phenomenon has been
observed in a subgroup of children with ADHD (Hoza et al.
2002; Owens et al. 2007; Rizzo et al. 2010) and, to a lesser
extent, in adults (Jiang and Johnston 2012; Knouse et al.
2005): they show a characteristic overestimation of com-
petence and/or performance, which is known as ‘‘positive
illusory bias’’. Children with ADHD show impaired error
monitoring and a lack of characteristic post-error slowing
in inhibitory response tasks (Schachar et al. 2004). As
mentioned above, in electrophysiological studies, this
impairment is reflected by a diminished amplitude of the
error-related negativity (Albrecht et al. 2008). In OCD
patients, in contrast, error-related negativity is enhanced
(Endrass et al. 2008).
Decision-making and reward-related processing
During the last years, neuropsychological OCD research
has focussed on decision-making and reward-related
learning, with inconsistent results for tasks with implicit or
complex reward contingencies (Cavedini et al. 2002;
Chamberlain et al. 2007; Dittrich and Johansen 2013;
Lawrence et al. 2006; Nielen et al. 2002; Watkins et al.
2005). However, a recent study based on large groups
indicates that impaired decision-making might be a key
feature in OCD (da Rocha et al. 2011) and already present
in childhood (Kodaira et al. 2012). More consistent deficits
have been found in reversal learning and response cost
paradigms: patients with OCD persist in their response
strategy in spite of changed reward contingencies (Cham-
berlain et al. 2008; Remijnse et al. 2006), or with the risk of
smaller gains (Chamberlain et al. 2007). It has been
hypothesized that impaired learning from feedback (Nielen
et al. 2009) might be at the origin of impaired cognitive
flexibility or an overcautious cognitive style. However,
learning from feedback seems intact when it leads to the
avoidance of negative consequences (Endrass et al. 2011).
Similarly, ADHD research on decision-making and learn-
ing from feedback has yielded mixed results, but there is
agreement that sensitivity to reinforcement is altered (Lu-
man et al. 2010; Modesto-Lowe et al. 2013). Children with
ADHD may opt for a smaller reward when this helps them
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to avoid waiting time (‘‘Delay Aversion’’ (DA)) (Bitsakou
et al. 2009; Sonuga-Barke 2002), and they are more
responsive to immediate than to delayed rewards (Sagv-
olden et al. 2005).
Contrasting OCD and ADHD
Vloet et al. (2010) directly compared neuropsychological
performances in adolescents with OCD or ADHD using a
serial reaction time task, developed to assess implicit
sequence learning, and a DA task in order to assess
abnormal motivational processes. Subjects with ADHD
chose less frequently the larger, more delayed reward
compared to those with OCD and controls. Subjects with
OCD showed impaired implicit learning. In contrast, the
ADHD group was unimpaired in their implicit learning
behaviour and the OCD group was not characterized by a
DA style. Within the OCD group, severity of obsessions
was associated with implicit learning deficits and impulsive
symptoms with DA in the ADHD group. In other tasks and
domains, however, the differentiation of the two disorders
is less evident: In a meta-analysis of the Stop-Task, Lips-
zyc and Schachar (2010) compared studies with different
psychiatric populations and found medium effect sizes for
deficits in stop signal reaction time for both ADHD
(g = 0.62) and OCD (g = 0.77), reflecting the diminished
speed of the inhibitory process. In a recent study comparing
adults with ADHD and OCD, Abramovitch et al. (2012)
found similar deficits of response inhibition in both disor-
ders, but higher self-reported impulsivity in the ADHD
group. These authors view executive function deficits in
OCD as an epiphenomenon caused by the overflow of
intrusive thoughts. According to their executive overload
model, cognitive deficits in OCD patients result from the
attempt to gain control over automatic processes in order to
reduce impulsive behaviour and lapses of attention. This
leads to increased consummation of cognitive resources
and in return to diminished effective control.
Neuropsychological profiles of subgroups
In ADHD as in OCD, apparent inconsistencies in neuro-
psychological findings have been explained by the exis-
tence of disorder-specific subgroups with differing
neuropsychological key deficits. In OCD, the paradox of
concurrent findings of diminished inhibitory control and
slow responding has been related to different symptom
dimensions, e.g. contrasting obsessional plus ‘‘slow deci-
sion-making’’ symptoms vs. compulsive plus ‘‘inhibition
deficit/rigid’’ symptoms (da Rocha et al. 2008; Friedlander
and Desrocher 2006; Mataix-Cols et al. 2005). Differential
neuropsychological profiles have been described e.g. in
patients with obsessions related to checking, symmetry/
ordering, or contamination (Hashimoto et al. 2011; Jang
et al. 2010), in ‘‘checkers’’ compared to ‘‘washers’’ (Ned-
eljkovic et al. 2009) and in different types of compulsion
(Fineberg et al. 2010). Similarly, contradicting neuropsy-
chological findings in ADHD have been explained by
different neurobiological origins and the ensuing hetero-
geneity of neuropsychological symptoms. Accordingly,
neurocognitive problems in children with ADHD may be
due to dysfunctional executive functions, to a dysfunctional
motivational/reward system, or to a combination of both
(Sonuga-Barke 2005). Recently, impaired time processing
has been suggested as a possible third pathway (Sonuga-
Barke et al. 2010).
Comorbidity and neuropsychological deficits
Comorbidity may attenuate or enhance neuropsychological
symptoms. Compared to ‘‘pure’’ ADHD, comorbid ADHD
with OCD seems to go along with attenuated neuropsy-
chological impairment (Arnold et al. 2005). The impact of
comorbid ADHD on neuropsychological deficits in OCD
patients, compared to ‘‘pure’’ OCD, has not yet been sys-
tematically investigated. However, comorbid ADHD in
childhood-onset OCD seems often to be associated with
hoarding symptoms (Fullana et al. 2013; Sheppard et al.
2010), and the neuropsychological profile of patients with
hoarding closely resembles that of ADHD inattentive
subtype patients, with symptoms of diminished sustained
attention (Tolin et al. 2011). Neuropsychological deficits
have been found to be less pronounced in OCD with
comorbid tics or Tourette disorder (Chang et al. 2007;
Rankins et al. 2005; Watkins et al. 2005), or differentially
affected in the presence of disorders from the autistic
spectrum (Zandt et al. 2007, 2009). In childhood ADHD,
comorbidity with tics/Tourette seems to result in a com-
bination of neuropsychological problems associated with
both disorders (Greimel et al. 2011; Shin et al. 2001).
When ADHD symptoms are present in high-functioning
autism or Asperger syndrome, neuropsychological deficits
may correspond to a combination of characteristics from
both disorders, with more severe deficits than in autism
alone (Yerys et al. 2009), but attenuated compared to
‘‘pure’’ ADHD (Sinzig et al. 2008; but see van der Meer
et al. 2012).
Functional neurochemistry of neurotransmitter
circuitry systems in OCD and ADHD
Neurotransmitter interactions and homeostasis are essential
features of normal behaviour. The seminal work of Albin
et al. (1989), Alexander and Crutcher (1990), DeLong et al.
(1985) and others implicated various ‘‘loop-systems’’ for
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the various phenotypes of human and animal behaviour.
The CST circuitry and its subregional connections play a
major role; hyperkinetic disturbances are based on reduced
stimulation of the substantia nigra pars reticulata and the
medial globus pallidus by the subthalamic nucleus (NST).
This can be caused by a disturbance of the NST (ballism)
or via reduced striatal inhibition of the lateral globus pal-
lidus (choreatic movement) (Reiner et al. 1988). In both
cases, the result is disinhibition of the thalamus which in
consequence leads to reduced feedback on cortical areas
(Crossman et al. 1985). Sensory impulses may be causal
for the hyperkinetic movements. Healthy individuals are
able to suppress such reactions (Albin et al. 1989). Striatal
nerve cells, which are sensitive for such sensory stimuli
(Crutcher and DeLong 1984), seem to play a key role in
uncontrolled sensory inputs (Paloyelis et al. 2012).
In the past, electrophysiological studies formed the basis
in the development of circuitry systems. More recent
experimental work has aimed at elucidating the interaction
of neurotransmitters in such ‘‘loops’’. Such work has been
reviewed in detail by Berger and Riederer (1992), Mehler-
Wex et al. (2006), Rommelfanger and Wichmann (2010),
Carlson et al. (2006), and many others. They all focus
primarily on disturbances of circuitry systems in motor
behaviour (hypo- and hyperkinetic syndromes such as
Parkinson’s disease (PD), Huntington’s Chorea, ADHD)
and less often on mood disorders, such as schizophrenia.
Due to seminal studies by the Viennese Oleh Horn-
ykiewicz and Walther Birkmayer in the early 1960s, which
found that a deficiency of dopamine in the striatum of
patients with PD could be substituted by L-DOPA, thereby
improving major symptoms of PD, akinesia, rigidity, and
tremor substantially, most work in the past has concen-
trated on ‘‘dopamine’’ as a major neurotransmitter for
‘‘motoricity’’ and ‘‘reward’’. There is a structural abnor-
mality in children with ADHD supporting the hypothesis of
a nigro-striatal defect (Romanos et al. 2010) underlying
motor behavioural alterations in this disorder. Additionally,
impulsivity, attention deficit, and mood changes seem to be
related to modulating circuits involving other brain areas.
Not only dopaminergic drugs can influence impulsivity
and compulsive behaviour. This is shown by recent
experiments demonstrating that blockade of noradrenergic
a2 receptors improves sustained attention and response
inhibition while a1- and b1- and b2-adrenergic receptor
blockade disrupted go performance and sustained attention
(Bari and Robbins 2013). Such data clearly demonstrates
noradrenergic neurotransmitter interactions within mood
circuitries. This is substantiated by genetic models using
dopamine transporter (DAT), norepinephrine transporter
(NET), and serotonin transporter (SERT) knockout mice.
These observations by Gallagher et al. (2013) correlate
with behavioural studies indicating that SERT knockout
mice display anxiety-like phenotypes, while NET knock-
outs and to a lesser extent DAT knockout mice display
antidepressant-like phenotypic features (Gallagher et al.
2013).
The D4 receptor is enriched in the prefrontal cortex and
thus has been implemented in mood disorders. Yuen et al.
(2013) described the restoration of glutamatergic trans-
mission by D4 receptors in stressed animals. It is of interest
that attention deficits can be induced by blocking N-methyl
D-aspartate (NMDA) receptors in the prefrontal cortex and
this is associated with enhanced glutamate release and
cyclic adenosine monophosphate response element binding
phosphorylation (Pozzi et al. 2011). Increased concentra-
tions of glutamate in the ACC of subjects with borderline
personality disorder with and without comorbid ADHD
have been detected in cross-sectional proton magnetic
resonance spectroscopy studies (Hoerst et al. 2010; Rusch
et al. 2010). The close relationship and interaction between
dopaminergic and glutamatergic neurotransmission has
been described in the late 1980s. From our own work, we
concluded that limbic dopaminergic activity is associated
with psychotic states, while the same behaviour can be
seen with reduced NMDA receptor channel blockade
(Berger and Riederer 1992). Quality, quantity, regional,
and subregional occurrence of such interaction determines
the phenotype of symptomology.
Another neurotransmitter of interest is serotonin. This
neurotransmitter is a ‘‘modulator’’, like a ‘‘fine tuning’’
system, that interacts with many other neurotransmitters
such as dopamine and glutamate. Therefore, it is not
unlikely to assume that serotonin is also involved e.g. in
impulsivity (Dalley and Roiser 2012). As summarized by
Hunt et al. (1982) the aminergic neurotransmitter hypoth-
eses for ADHD have been developed in particular in the
1980s. These studies included the measurement of seroto-
nin in blood (Haslam and Dalby 1983) as well as mea-
surements of total, free, and bound tryptophan (Ferguson
et al. 1981; Hoshino et al. 1985; Irwin et al. 1981) with in
part discrepant results. More recent studies demonstrate an
inverse relationship between trait impulsivity and the acute
tryptophan depletion effect on reactive aggression after low
provocation in patients with adolescent and adult ADHD
(Kotting et al. 2013; Zimmermann et al. 2012). While there
seems to be a relationship between acute tryptophan
depletion and attentional performance in adult patients with
ADHD (Mette et al. 2013), there is no such effect on verbal
declarative memory in young patients with ADHD (Zepf
et al. 2013) and on processing affective prosody in male
adults with ADHD (Grabemann et al. 2013).
As already elaborated in chapter 2, the fronto-striatal
loop plays a major although not exclusive role in OCD
symptomology. This correlates with findings of e.g. Gon-
c¸alves et al. (2011) and the fact that frontal-subcortical
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circuits are involved in behavioural aspects (Cummings
1995).
Furthermore, an OFC pathological neural substrate
underlying olfactory identification impairment, impulsiv-
ity, and OCD has been described by Bersani et al. (2013).
In contrast, deficits in visual memory, executive functions,
and attention indicate that regions outside of the OFC may
be involved in OCD (Bersani et al. 2013). The specific
involvement of the NST in emotional processes in humans
has been further described by Buot et al. (2012). These
authors showed that the ventral part of the NST processes
the emotional violence of stimuli independently of the
motor context and that dopamine enhances the processing
of pleasant information (Buot et al. 2012). In addition,
experimental work in monkeys suggest that overactivity of
the ventral anterior and medial dorsal nuclei of the thala-
mus provokes compulsive-like behaviours and neurovege-
tative manifestations including anxiety in patients with
OCD (Rotge et al. 2012).
While plasma catecholamines and metabolites are not
changed in OCD (Benkelfat et al. 1991) concurring with no
change in cerebrospinal fluid (CSF) concentrations of
biogenic amines and metabolites (Leckman et al. 1995),
supersensitive beta-adrenergic receptors are measured by
detecting adenylate cyclase activity in platelets of OCD
patients (Marazziti et al. 2009).
The role of dopamine in OCD is becoming more sig-
nificant especially since the augmentation of dopaminergic
receptor antagonists shows positive treatment responses
(Koo et al. 2010). In fact, PET-studies labelling D1
receptors have demonstrated down regulation in the stria-
tum (Olver et al. 2009) and ACC (Olver et al. 2010).
Imaging studies also show a reduction of D2 binding
(Nikolaus et al. 2010). Increased dopaminergic activity
might contribute to these findings. This corresponds to the
findings that metabolism via catecholamine-O-methyl-
transferase (COMT) and monoamine-oxidase-A (MAO-A)
demonstrates polymorphisms in both these genes in males
as shown by a meta-analysis by Taylor (2013), while
DAT1- and DRD3-polymorphisms could not be identified
so far.
As with disturbances in the glutamatergic system, there
is evidence for significant increases of both glutamate and
glycine in the CSF of OCD patients (Bhattacharyya et al.
2009). As indicated by a multivariate analysis of variance,
CSF glycine concentrations were even higher in those OCD
patients who had autoantibodies compared with those
without (Bhattacharyya et al. 2009).
Using proton magnetic resonance spectroscopy (MRS),
female OCD patients had a significantly reduced concen-
tration of glutamate–glutamine in subareas of the ACC. In
addition, male and female OCD patients had higher con-
centrations of myoinositol-containing compounds in their
right rostral and dorsal ACC (Yucel et al. 2008). However,
in the medial prefrontal cortex (MPFC), voxel-based
imaging including the pregenual ACC (Simpson et al.
2012) could not detect glutamate–glutamine abnormalities
in unmedicated OCD adults, while MPFC gamma-amino-
butyric acid (GABA) levels were decreased. MRS studies
measuring N-acetylaspartate showed significantly lower
concentrations in the left head of the caudate nucleus
(HOC) in non-medicated patients with OCD compared to
medicated ones, while preliminary data suggest a correla-
tion of behaviour therapy with a decrease in glutamate–
glutamine in the right HOC (Whiteside et al. 2012).
It remains to be clarified in further studies whether OCD
is a hyperglutamatergic and ADHD a hypoglutamatergic
condition with prefrontal brain regions being especially
affected as hypothesized by Carlsson (2001). Although
there is ample evidence for an involvement of glutama-
tergic perturbations in OCD, it is the resulting treatment
strategy that proves or disproves this concept. Therefore, it
is an interesting notion that lamotrigine augmentation of
selective serotonin re-uptake inhibitor (SSRI) treatment has
been regarded as an effective therapeutic strategy (Bruno
et al. 2012). Memantine add-on to fluvoxamine signifi-
cantly improved short-term outcomes in patients with
moderate to severe OCD (Ghaleiha et al. 2013; Hezel et al.
2009; Stewart et al. 2010).
Adjunctive glycine treatment (a NMDA receptor ago-
nist) approached efficacy in OCD patients (Greenberg et al.
2009) while ketamine, a potent non-competitive NMDA
receptor antagonist, has been studied in treatment-refrac-
tory OCD. Ketamine effects on OCD symptoms, in contrast
to depressive symptoms, did not seem to persist or progress
after the acute effects of ketamine had dissipated (Bloch
et al. 2012).
The ‘‘serotonin hypothesis’’ of OCD has been developed
in the 1980s (March et al. 1989) and was based on CSF
concentrations of 5-HIAA, which were significantly
increased in OCD (Insel et al. 1985). Pharmacological
strategies with zimelidine, a 5-HT uptake inhibitor,
reduced CSF-5-HIAA concentrations but were clinically
ineffective (Insel et al. 1985). Moreover, the behavioural
responses of OCD patients to m-chlorophenylpiperazine
(MCPP) and tryptophan treatment had no effects on OCD
symptoms (Charney et al. 1988). However, clomipramine
improved symptoms worsened with metergoline, a 5-HT
antagonist, in patients who had improved with clomipra-
mine, a semiselective 5-HT uptake inhibitor (Murphy et al.
1989). MCPP, a 5-HT receptor agonist, increased anxiety,
depression, and dysphoria in untreated OCD patients
(Murphy et al. 1989). Regarding Cochrane analyses and
meta-analyses, SSRIs are the first choice of medication for
OCD in children and adults and are able to alleviate OCD
symptoms significantly (Westenberg et al. 2007).
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Serotonin-norepinephrine re-uptake inhibitors are less
effective and only third choice, but have been described as
showing fewer side effects (Sansone and Sansone 2011).
All in all, SSRIs lack efficiency in ADHD while they are
highly efficient in OCD. In contrast, dopaminergic and
noradrenergic interventions are effective in many although
not all patients with ADHD. If we summarize the
involvement of various neurotransmitters in ADHD, the
following rank order is envisaged: dopamine–noradrena-
line–glutamate–serotonin, while for OCD, the following
rank order is envisaged: serotonin–glutamate = dopa-
mine–noradrenaline.
Genetic aspects in OCD and ADHD
Twin and family studies
OCD and ADHD twin and family studies indicate high
familiality in both disorders (Walitza et al. 2010; Franke
et al. 2012). The heritability of obsessive compulsive
symptoms ranges from 0.45 to 0.65 in children and from
0.27 to 0.47 in adults (van Grootheest et al. 2005). For
ADHD, the heritability was estimated to be around
70–80 % (Faraone et al. 2005). However, more recent
quantitative systematic approaches, which took into
account possible biases of previous twin studies (such as
lack of power to detect sibling interactions and the cor-
rection used for contrast effects), concluded that genetic
factors explained 60 % of the variance of ADHD (Wood
and Neale 2010). Recently, it was reviewed that many twin
studies vary in several phenotypic and measurement
aspects, thereby strongly influencing heritability estimates,
in turn indicating that one should be cautious regarding the
interpretation of these results (Freitag et al. 2010). In
addition, the strong evidence supporting the notion that
ADHD is an extreme of a continuous trait lead Larsson
et al. (2012) to investigate the genetic links in twins
between the extreme and the subthreshold range of ADHD
symptoms. They found a strong genetic link between the
extreme and the subthreshold variation, with almost iden-
tical group heritability estimates of around 0.60 for the
diagnostic (prevalence 1.78 %) and screening (prevalence
9.75 %) criteria of ADHD (Larsson et al. 2012). Moreover,
Larsson et al. (2013) described high heritability of ADHD
(0.88, 95 % CI 0.83–0.93) for the entire twin sample
composed of over 50,000 twins, while shared environ-
mental effects were non-significant. Similarly, in OCD, a
more recent twin study (van Grootheest et al. 2008) indi-
cated that genetic factors contributed significantly to vari-
ations in obsessive compulsive symptom liability that were
dependant on age: only 27 % at the age of 12 years, but
57 % at the age of 14 years, and 54 % at the age of
16 years. There were no sex differences in heritability,
while gender difference did influence prevalence (higher
prevalence in girls at age 14 and 16). Only at age 12 did
environmental factors shared by children from the same
family contribute significantly (16 %) to individual dif-
ferences in obsessive compulsive symptom scores.
Family studies showed that first-degree relatives of
patients with OCD were affected by OCD considerably
more frequently than relatives of healthy control subjects
(Bellodi et al. 1992; Pauls et al. 1995; Nestadt et al. 2000;
Hanna et al. 2005a, b; do Rosario-Campos et al. 2005).
However, in a representative recent study of Steinhausen
et al. (2013) no effect of age of onset on heritability was
found. Family studies showed that there is a type of OCD
which might be more familial and another type which is
probably more de-novo and perhaps triggered more by
environmental factors. Furthermore, the studies showed
that early-onset OCD seems to be a more genetic and
neurobiological condition. Similarly, familial studies have
shown that the risk of ADHD among parents and siblings
of children who had ADHD is increased starting at two-up
to eightfold higher (Wilens et al. 2005). Adoption and twin
studies can help to separate, although not completely,
genetic from environmental factors observed in family
studies (Wood and Neale 2010). Adoption studies have
unequivocally found that biological relatives of children
with ADHD are more likely to be hyperactive compared to
adoptive relatives (Faraone and Khan 2006).
Linkage studies
Many linkage analysis studies have been conducted in
ADHD samples including child as well as adult patients
with ADHD (Franke et al. 2012). Several chromosome
regions have been suggested to be significantly linked to
ADHD (see Table 1). A meta-analysis including 7/9
independent studies showed that the distal part of chro-
mosome 16q is linked to ADHD (contains e.g. the CDH13
genes) (Zhou et al. 2008). This has been also shown in
genome-wide association studies (GWAS, Lesch et al.
2008).
Similarly, several linkage studies (Arcos-Burgos et al.
2004; Hebebrand et al. 2006; Romanos et al. 2008) as well
as one meta-analysis (Ogdie et al. 2006) indicate a sig-
nificant linkage on chromosome 5 in a region containing
the dopamine D1 receptor as well as the dopamine trans-
porter genes (DAT1, SLC6A3). These candidate genes
have also been found in many association studies to be
significantly associated with ADHD (Nemoda et al. 2011).
Therefore, we assume that these two dopaminergic genes
seem to contribute to ADHD.
In comparison with ADHD, only five genome-wide
linkage (GWL) studies of OCD have been published so far
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(see Table 1). In all five studies, no significant genome-
wide evidence for linkage was detected according to
standard guidelines for linkage studies (Lander and
Kruglyak 1995). However, several loci displayed sugges-
tive evidence for linkage findings. In particular,
chromosome 1 seems to repeatedly show evidence for
linkage with OCD (Hanna et al. 2007; Shugart et al. 2006;
Ross et al. 2011; Mathews et al. 2012). Another frequent
finding is from Hanna et al. (2002) who found in a second
GWL scan the maximum linkage signal on chromosome
Table 1 Significant linkage
findings from genome-wide
scans and meta-analysis of
ADHD and nominal significant
findings in OCD
ADHD attention deficit
hyperactivity disorder, GWL
genome-wide linkage study,
M meta-analysis, OCD
obsessive compulsive disorder
Chromosome Chromosomal region ADHD OCD
1 1p21 GWL (Ross et al. 2011)
1p36 GWL (Mathews et al. 2012)
1q GWL (Shugart et al. 2006)
GWL (Hanna et al. 2007)
1q25.1 GWL (Romanos et al. 2008)
1q25.3 GWL (Romanos et al. 2008)
2 2p14 GWL (Mathews et al. 2012)
2p25.1 GWL (Saviouk et al. 2011)
2q21.1 GWL (Rommelse et al. 2008)
2q35 GWL (Romanos et al. 2008)
3 3q27–28 GWL (Shugart et al. 2006)
4 4q13.2 GWL (Arcos-Burgos et al. 2004)
5 5p GWL (Hebebrand et al. 2006)
5p13 GWL (Friedel et al. 2007)
5p13.1 M (Ogdie et al. 2006)
GWL (Romanos et al. 2008)
5q13 GWL (Mathews et al. 2012)
5q33.3 GWL (Arcos-Burgos et al. 2004)
6 6p25 GWL (Mathews et al. 2012)
6q GWL (Shugart et al. 2006)
6q22-23 GWL (Romanos et al. 2008)
7 7p GWL (Shugart et al. 2006)
9 9p24 GWL (Hanna et al. 2002)
9q22 GWL (Romanos et al. 2008)
9q31.1–33.1 GWL (Romanos et al. 2008)
9q33 GWL (Romanos et al. 2008)
10 10p13 GWL (Mathews et al. 2012)
10p15 GWL (Hanna et al. 2007)
11 11q22 GWL (Arcos-Burgos et al. 2004)
13 13q12.11 GWL (Rommelse et al. 2008)
14 14q12 GWL (Romanos et al. 2008)
15 15q GWL (Shugart et al. 2006)
15q11.2–13.3 GWL (Romanos et al. 2008)
15q14 GWL (Ross et al. 2011)
16 16p12.3–12.2 GWL (Romanos et al. 2008)
16p13 M (Zhou et al. 2008)
GWL (Ogdie et al. 2003)
16q23.1–24.3 M (Zhou et al. 2008)
16q24 GWL (Ross et al. 2011)
17 17p11 GWL (Arcos-Burgos et al. 2004)
17p12 GWL (Ross et al. 2011)
18 18q11.2–12.3 GWL (Romanos et al. 2008)
18q21.31–21.32 GWL (Saviouk et al. 2011)
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10p15. Concordantly, Mathews et al. (2012) also found a
linkage signal in a nearby region (10p13). Chromosome 10
seems to show a more specific contribution to OCD since
no findings were reported in ADHD (see Table 1).
Association studies
To date, although several GWAS as well as meta-analyses
for association studies in ADHD have been conducted, no
single single-nucleotide polymorphisms (SNP) or poly-
morphism has been found to be affected in ADHD (see
Table 2; Zhang et al. 2012). Furthermore, similar as in
ADHD, no single SNP or polymorphism has been found to
be affected in OCD, as found in the only GWAS published
to date (Stewart et al. 2013b), in which no SNP reached
genome-wide significance, as well as from the meta-ana-
lysis conducted by Taylor (2013). Nevertheless, it seems
that dopaminergic, serotonergic, noradrenergic, synaptic,
and growth factor genes are involved in ADHD, while in
OCD, the serotonergic and glutamatergic genes seem to
play a greater role (see Table 2).
Dopaminergic genes
Although SSRIs are the first-line treatment for OCD, in
cases of non-response, augmentation of low-dose neuro-
leptics is sometimes effective (Komossa et al. 2010). This
implies that there is involvement of dopamine-related
genes in OCD. Nevertheless, only COMT showed some
significant association in OCD after an extensive meta-
analysis (Taylor (2013); Table 2). Clinical studies with
responders and non-responders to drug treatment were
stratified according to dopamine D2 Taq/A and COMT
Val158Met genotypes (Vulink et al. 2012). There was no
significant difference in genotype distribution or allele
frequencies of the COMT or dopamine receptor D2 (DRD2)
between responders and non-responders to citalopram with
quetiapine. However, OCD patients with the Met/Met
genotype (48 %) of the COMT polymorphisms showed a
treatment response to 10-week citalopram in drug-free/
drug-naive OCD patients (Vulink et al. 2012). This is in
line with some clinical findings showing that lower activity
of COMT associated with the Met allele lead to poorer
executive function in OCD (Tukel et al. 2013). Recently,
COMT mRNA was shown to be expressed significantly
lower in patients with OCD compared to controls in
peripheral blood samples (Wang et al. 2009). Influence of
variations in the DAT1 and COMT genes on neural acti-
vation during response inhibition with different activation
during inhibition have been described. Inhibitory control
seems therefore associated with variation of dopamine
function (Congdon et al. 2009). But recent studies, gen-
ome-wide linkage scans and GWAS, are contradictory
considering the ‘‘classic’’ dopaminergic genes like COMT.
That resulted in no significant association with ADHD after
meta-analysis (Sun et al. 2013; Zhang et al. 2012). While
the COMT-SNP rs4680 (Val158Met) Met allele reduces
COMT enzyme activity and is associated with impulsive-
ness and substance abuse in ADHD, Soeiro-De-Souza et al.
(2013) compared the Met/Met genotype with the Val/Val
genotype in healthy individuals. These authors demon-
strated that the rs4680 Met/Met genotype was associated
with higher impulsivity on the BIS-11 s-order factor Non-
planning scale. Therefore, such data are in line with the
suggestion that increased dopamine concentration induces
impulsivity and substance abuse depending on the sensi-
tivity of motor- and limbic circuitry systems (Soeiro-De-
Souza et al. 2013). Involvement of dopamine systems in
the pathology of ADHD is also evident from PET-studies
with 11C-altropane. It could be shown that both ADHD and
the 30-UTR (SLC6A3) DAT1 polymorphism had additive
effects on 11C-altropane DAT binding (Spencer et al.
2013). Similarly, a single-photon emission computed
tomography meta-analysis in healthy controls could show
nominal higher levels of striatal DAT in the 9-repeat allele
carriers (Costa et al. 2011). According to many association
studies followed by meta-analysis, it has been shown that
the 10-repeat allele of the DAT1 is a risk allele for ADHD
in childhood (Gizer et al. 2009; Table 2), while persistent
ADHD in adults was associated with the 9-repeat allele
(Franke et al. 2010), findings that might point to a regu-
latory effect of DAT in brain development. Nevertheless,
such association could not be confirmed in a recent meta-
analysis for OCD (Taylor 2013; Table 2), pointing to a
unique effect in ADHD.
Dopaminergic receptors (D1–D5) are essential in mod-
ulating behaviour. The high risk of D2, D4, and D5
receptor polymorphisms in ADHD has been reviewed by
Wu et al. (2012). Disruption of D2 signalling in the ventral
striatum impairs motivation. In contrast, postsynaptic
overexpression in the nucleus accumbens increases in
animals the willingness to expend efforts to obtain a goal
(Trifilieff et al. 2013). Furthermore, DRD4 and tyrosine
hydroxylase (TH) polymorphisms are associated with
activity–impulsivity-related traits in dogs (Wan et al.
2013). Several studies suggest that the length of the DRD4
repeat affects the activation of the receptor as well as the
mRNA expression of the gene (Nemoda et al. 2011). Meta-
analysis in ADHD revealed a significant association
between the 7-repeat allele of the DRD4 exon 3 VNTR
(OR 1.33, 95 % CI 1.15–1.54) and the disorder (Gizer et al.
2009), while association of the DRD4 4-repeat allele and
OCD was indicated by a case–control study (Camarena
et al. 2007) and by a family-based study (Walitza et al.
2008), whereas an increased frequency of the DRD4
7-repeat allele was shown in a late-onset OCD group
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(Hemmings et al. 2004), and in a subgroup of OCD patients
with comorbid tics (Cruz et al. 1997). Nevertheless, in a
recent meta-analysis, this association to OCD could not be
confirmed (Taylor 2013; Table 2). Signalling properties
and regulation of DRD4 as well as the interaction of DRD4
in modulating GABAergic transmission has been reviewed
by Furth et al. (2013). As the adenosine A2A receptor
(ADORA2A) is linked to dopaminergic transmission,
Molero et al. (2013) studied the relationship between
ADORA2A gene polymorphisms and ADHD traits in 1,747
Table 2 Genetic risk factors in
ADHD versus OCD
M? meta-analysis showing
positive association, M- meta-
analysis showing negative
association, ± findings are
contradictory, ? ? more
positive association results
compared to the negative
results, ? suggestive evidence
(no replication yet), - - more
negative association results
compared to the positive results,
- single negative study, not
available (n.a): PubMed search
did not yield any result. For
ADHD, data were extracted
using the ADHDgene database
(http://adhd.psych.ac.cn/index.
do), Neale et al. (2010b), Shif-
frin et al. (2013), Wu et al.
(2012), Forero et al. (2009), Sun
et al. (2013) and Gizer et al.
(2009). For OCD, data were
extracted from reviews of Nic-
olini et al. (2009), Nestadt et al.
(2010), Walitza et al. (2010),
Pauls (2010), Nemoda et al.
(2011), Stewart et al. (2013a)
and Taylor (2013)
Genes Chromosomal location ADHD OCD
Dopaminergic DRD1 5q35.2 M- n.a.
DRD2 11q23.2 M? M-
DRD3 3q13.31 M- M-
DRD4 11p15.5 M? M-
DRD5 4p16.1 M? n.a.
TH 11p15.5 M- n.a.
MAOB Xp11.3 - - n.a.
COMT 22q11.21 M- M? (men)
DAT1 (SLC6A3) 5p15.33 M? M-
DDC 7p12.1 ? ? n.a.
Serotonergic SERT (SLC6A4) 17q11.2 M? M?
HTR2A 13q14.2 M- M? (early onset)
HTR1A 5q12.3 ? n.a.
HTR1B 6q14.1 M? M-
HTR1D 1p36.12 ± ?
HTR2C Xq23 - - M-
TPH2 12q21.1 M? ±
TPH1 11p15.1 M- –
MAOA Xp11.3 ?? M-
Noradrenergic NET (SLC6A2) 16q12.2 M- –
DBH 9q34.2 M? n.a.
ADRA2A 10q25.2 M- n.a.
ADRA2C 4p16.3 - - n.a.
Cholinergic CHRNA4 20q13.33 M- n.a.
Glutamatergic/GABAergic GRIN2A 16p13.2 - - n.a.
GRIK2 6q16.3-q21 n.a. ? ?
SLC1A1 9p24 n.a. M±
GABRB3 15q12 n.a. ??
SLC6A1 3p25-p24 ? n.a.
Synaptic SNAP25 20p12.2 M? n.a.
CDH13 16q23.3 ± n.a.
CTNNA2 2p12 ± n.a.
Others BDNF 11p14.1 M- M±
BDKRB2 14q32 n.a. ??
CHRM5 15q26 n.a. ??
CHRNA1 2q31.1 n.a. ??
UBE3A 15q11.2 n.a. ??
TNFA 6p21.2 n.a. ??
GLRB 4q31.3 n.a. ??
LPHN3 4q13.1 ? ? n.a.
ASTN2 9q33.1 ± n.a.
OLIG2 21q22.1 n.a. ? ?
NTRK2 9q21.33 ± ? ? (female)
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twins. One of the SNPs, rs35320474, showed a significant
correlation to ADHD traits (Molero et al. 2013).
In conclusion, it seems that dopamine-related genes are
much more associated with ADHD than with OCD (see
Table 2).
Serotonergic genes
Selective serotonin re-uptake inhibitors block the SERT
and represent the most effective pharmacological treatment
of early and late OCD. Most association studies in OCD
have therefore investigated serotonergic genes (see
Table 2). This is in contrast to ADHD where pharmaco-
therapy is focused on the regulation of dopaminergic and
noradrenergic dysfunction. The most frequently studied
gene in OCD is SERT [SLC6A4], with its functional
polymorphism in the upstream region termed 5-HTTLPR,
which involves an insertion (L-[long] allele)/deletion (S-
[short] allele) polymorphism. In comparison with the
S-allele, the L-allele has been reported to exert an
increased transcriptional activity and an increased basal re-
uptake of 5-HT in vitro (Heils et al. 1996; Lesch et al.
1996; Murphy and Lesch 2008). The L-allele is therefore
referred to as the gain-of-function variant of the serotonin
transporter. In contrast to anxiety disorders, it has been
observed in OCD that the L-allele is associated with the
disorder, in particular in early onset (Bloch et al. 2008;
Taylor 2013; Walitza et al. 2005). Similarly as for OCD,
the L-allele of the SERT was found to be significantly
associated with ADHD (OR 1.17 95 % CI 1.02–1.33)
(Gizer et al. 2009). This might imply the similarity
in dysfunction of impulse control in both disorders, caused
by dysfunctions of the serotonergic pathways. Neverthe-
less, some contradicting results were reported in which no
significant association between 5-HTTLPR and ADHD was
found in a meta-analysis (Forero et al. 2009).
In line with the serotonergic hypothesis, a significant
association with the rs6311 A-allele carriers of the sero-
tonin 2A receptor (HTR2A) with OCD was confirmed by a
meta-analysis (Taylor 2013; Table 2). However, this gene
seems to be specific to OCD as no positive findings were
reported for ADHD (see Table 2).
Another gene related to the serotonergic system is the
brain-specific tryptophan hydroxylase-2 (TPH2), the rate-
limiting enzyme in 5-HT synthesis in the brain, that was
studied for the first time for its association in early-onset
OCD (Mossner et al. 2006) and in ADHD by our groups
(Walitza et al. 2005). This gene, according to a meta-
analysis by Gizer et al. (2009), showed a significant
association with ADHD, while it failed to associate with
OCD after meta-analysis (Taylor 2013), probably
because the numbers of studies with OCD are still too
low.
In conclusion, it seems that the serotonin-related genes
have some common gene associated with OCD and ADHD
(e.g. SERT), although some genes seem to be unique to one
disorder (e.g. HTR2A for OCD; HTR1B, TPH2 and MAOA
for ADHD).
Noradrenergic genes
Since one of the therapeutic targets of medication (such as
atomoxetine) in ADHD is the norepinephrine transporter
(NET), this gene and related genes have been studied. Yet,
only the dopamine beta hydroxylase (DBH), the enzyme
that synthesizes norepinephrine from dopamine, was found
to be associated with ADHD after a meta-analysis (Gizer
et al. 2009). While neither NET nor other noradrenergic
genes were found to be associated with ADHD or with
OCD (see Table 2).
Glutamatergic genes
The neuronal glutamate transporter (SLC1A1) gene on
9p24 is one of the few candidate genes for OCD that was
investigated due to its localization within a linkage peak by
Hanna et al. (2002). The role of this glutamate transporter
gene in OCD is also supported by the observation that the
anti-glutamatergic drug riluzole can be beneficial in the
treatment of OCD and by the finding of elevated glutamate
levels in the CSF of OCD patients (Pittenger et al. 2011).
Further studies of glutamatergic neurons and SLC1A1 in
particular are therefore warranted in early- and adult-onset
OCD (Wu et al. 2013a, b). Identification and character-
ization of three alternative SLC1A1/EAAC1 (excitatory
amino-acid transporter 1) mRNAs, P2, ex2skip, and
ex11skip (Porton et al. 2013), gave evidence that all iso-
forms inhibit glutamate uptake from the full-length
EAAC1 transporter (Porton et al. 2013). While Wang et al.
(2010) did find the variant T164A in one family, these
authors did not find statistical differences in genotype and
allele frequencies of common SNPs in SLC1A1. All in all,
however, the results on SLC1A1 in OCD are at discrep-
ancy. Samuels et al. (2011) genotyped 111 SNPs in or near
SLC1A1 and conducted family-based association analyses
in 1,576 participants in 377 families. None of the sur-
rounding markers were in linkage disequilibrium with
rs301443 (SNP 7.5 kb downstream of the SLC1A1 gene)
nor were any associated with OCD. These authors, how-
ever, found that rs4740788 was associated with OCD in all
families and in families with affected males. A three-SNP
haplotype (rs4740788–rs10491734–rs10491733) was
associated with OCD in the total sample (Samuels et al.
2011). SLC1A1 rs3056 variant could be shown to be
associated with increased total, left, and right thalamic
volume in OCD (Arnold et al. 2009). Also, there might be a
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common locus for OCD and autism spectrum disorders at
rs301443 residing between SLC1A1 and JMJD2C (Lysine-
specific demethylase 4C/KDM4C) at 9p24 (Kantojarvi
et al. 2010). Non-significant trends were identified by
Taylor’s meta-analysis report (2013) for the glutamate-
related polymorphism rs3087879. In agreement, a much
less optimistic message regarding an association between
OCD and the 30-region of SLC1A1 is based on a recent
meta-analysis (Stewart et al. 2013a). Nevertheless, the
glutamatergic-related genes seem to be unique for OCD,
since no significant association has to date been found in
ADHD (see Table 2).
Synaptic genes
In regard to the synaptic genes, these have come to atten-
tion after GWAS findings in ADHD (Lasky-Su et al. 2008;
Neale et al. 2010a; Neale et al. 2010b; Lesch et al. 2008).
In particular the genes coding to synaptosomal-associated
protein 25 (SNAP25), cadherin 13 H-cadherin (CDH13),
and catenin (cadherin-associated protein) alpha-2
(CTNNA2) but also others (see Table 2). Indeed, SNAP25
has been further investigated in independent studies and
meta-analyses showing significant association with ADHD
(Gizer et al. 2009; Galvez et al. 2013). Furthermore, in a
recent study, the variant rs362990 on the SNAP25 gene was
associated with ADHD in which the risk A-allele was also
associated with additive decrease in the expression of the
SNAP25 transcript in the inferior frontal gyrus of 89
unaffected adult post-mortem tissue (Hawi et al. 2013).
Moreover, reduced SNAP25 levels in developing gluta-
matergic synapses alter short-term plasticity, in which
glutamatergic neurotransmission is enhanced (Antonucci
et al. 2013). Still, the synaptic-related genes should be
further investigated in more depth in order to confirm
GWAS and other association studies in ADHD. In contrast,
in OCD, such studies have not yet been conducted, and
therefore, no conclusion in regard to their involvement in
the disorder can be conveyed.
Conclusions
OCD and ADHD are frequent psychiatric disorders which
are highly comorbid with each other and with other psy-
chiatric symptomatology. In early-onset OCD, ADHD is
one of the most common comorbidities. Structural and
functional imaging findings have shown abnormalities
converging with a failure of CST circuit function respon-
sible for cognitive control and performance monitoring
processes in both ADHD and OCD patients.
Neuropsychological tests and corresponding brain acti-
vation studies showed, for example, deficits in response
inhibition common to both disorders. According to the
nature of their symptoms situated at the opposite ends of
the impulsive–compulsive spectrum, either hypo- or hy-
peractivation of affected brain structures such as basal
ganglia or the mesial frontal cortex was reported. Never-
theless, the causes of the deficits may be different. In the
case of OCD, they could be caused by the overflow of
intrusive thoughts, whereas in ADHD, it might be due to a
lack of inhibitory control and to an impulsive response
style. Abnormal inhibitory processes e.g. may therefore be
responsible for both, the perseverative, compulsive symp-
toms characterizing patients with OCD and the disinhibit-
ed, impulsive behaviours seen in patients with ADHD.
Neurochemically ADHD and OCD are varied in particular
in their pathobiochemical and pathogenetic involvement of
dopamine (ADHD) and serotonin (OCD). Fronto-striatal-
and orbito-frontal circuitries reflect significant differences
from a morphological and neurochemical point of view.
The ACC and MPFC have recently received major interest
especially in OCD. The molecular genetic findings corre-
spond well to the neurochemical and imaging perspective.
Linkage studies show for ADHD, regions of significant
linkage on chromosome 16q, containing the CDH13 gene
and for chromosome 5 containing the DRD1 and the DAT1
genes, supporting the strong evidence for the involvement
of the dopaminergic system in the aetiology of ADHD. In
regard to OCD, no significant genome-wide evidence for
linkage has been so far detected; however, there is some
evidence for linkage on chromosome 1 and 10. In contrast
to ADHD, especially association studies in OCD sup-
ported the contribution of serotonergic and also gluta-
matergic genes with the disorder. For some OCD
phenotypes, augmentation of SSRIs with dopaminergic-
based treatments is recommended. In the case of ADHD
so far, dopaminergic- and noradrenergic-based medication
remains the first choice medication. In summary, multi-
modal studies investigating the aetiological factors of
psychiatric disorders and phenotypes have the potential to
contribute to the ongoing development of more effective
and specific treatment strategies not only for the different
disorders but also for clinical presentations of broader
phenotypes.
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